Mount Sinai School of Medicine’s New Gene Therapy Proves Effective in Treating Severe Heart Failure
Mount Sinai researchers have developed a way to stimulate production of an enzyme that enables failing hearts to pump more effectively. Researchers at Mount Sinai School of Medicine have developed a new gene therapy that is safe and effective in reversing advanced heart failure. SERCA2a (produced as MYDICAR®) is a gene therapy designed to stimulate …